FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309308595> ?p ?o ?g. }

• W4309308595 endingPage "387" @default.
• W4309308595 startingPage "378" @default.
• W4309308595 abstract "Parvovirus B19 (B19V) is associated with a wide range of clinical manifestations. The major presentation is erythema infectiosum. However, a persistent infection may cause pure red cell aplasia and chronic anemia in immunocompromized patients. The B19V seroprevalence varies with age and geographical location.To determine the B19V serological status and DNAemia in kidney, liver, and pancreas transplant candidates.Patients who underwent kidney, liver, or simultaneous kidney and pancreas/liver transplantation between January 2021 and May 2022 were included in the study. The serum samples were collected before transplantation. For detection of B19V DNA, a LightMix Kit B19V EC (TIB MOLBIOL, Berlin, Germany) was used. B19V IgM and IgG antibodies were detected using a commercial ELISA test (Euroimmun, Lübeck, Germany).One hundred and thirty-one transplant candidates were included in the study, 71.0% male, with an average age of 53.27 years ± 12.71 years. There were 68.7% liver, 27.5% kidney, 3.0% simul taneous pancreas/kidney transplant (SPKT), and 0.8% simultaneous liver/kidney transplant recipients. No patients had detectable B19V DNA. B19V IgG seroprevalence was 77.1%. No acute or recent infections were detected (IgM antibodies). There was no difference in the mean age of seronegative and seropositive patients (51.8 years ± 12.9 years vs 53.7 years ± 12.7 years, t = -0.603; P = 0.548). Although seropositivity was lower in patients aged less than 30 years (66.6%) compared to the patients aged 30-59 years and > 60 years (80.4% and 78.1%, respectively), this difference was not significant. In addition, there was no difference in seropositivity between male and female transplant candidates, 76.3% and 78.9% (χ2 = 0.104; P = 0.748). The seroprevalence did not differ among organ recipients, with 77.8%, 80.6%, and 50.0% for liver, kidney, and SPKT, respectively, (χ2 = 5.297; P = 0.151). No significant difference was found in the seroprevalence in kidney transplant patients according to dialysis modality. Seroprevalence was 71.1% in hemodialysis patients, and 100% in peritoneal dialysis patients (χ2 = 0.799; P = 0.372).The B19V seroprevalence is expectedly high among kidney, liver, and pancreas transplant candidates, but there are still 22.9% of seronegative individuals who remain at risk for primary disease and severe manifestations. Further research should elucidate the necessity of B19V screening in peri-transplant management." @default.
• W4309308595 created "2022-11-26" @default.
• W4309308595 creator A5019327453 @default.
• W4309308595 creator A5030807436 @default.
• W4309308595 creator A5035932638 @default.
• W4309308595 creator A5041107229 @default.
• W4309308595 creator A5049150425 @default.
• W4309308595 creator A5049501924 @default.
• W4309308595 creator A5070484679 @default.
• W4309308595 creator A5080492388 @default.
• W4309308595 creator A5083544553 @default.
• W4309308595 date "2022-11-18" @default.
• W4309308595 modified "2023-09-25" @default.
• W4309308595 title "Parvovirus B19 status in liver, kidney and pancreas transplant candidates: A single center experience" @default.
• W4309308595 cites W1507572598 @default.
• W4309308595 cites W1970103039 @default.
• W4309308595 cites W1973901050 @default.
• W4309308595 cites W1992530380 @default.
• W4309308595 cites W2010074177 @default.
• W4309308595 cites W2015426350 @default.
• W4309308595 cites W2022277835 @default.
• W4309308595 cites W2022668167 @default.
• W4309308595 cites W2023851094 @default.
• W4309308595 cites W2028973331 @default.
• W4309308595 cites W2029236492 @default.
• W4309308595 cites W2029270351 @default.
• W4309308595 cites W2034335927 @default.
• W4309308595 cites W2035944585 @default.
• W4309308595 cites W2052158840 @default.
• W4309308595 cites W2072324749 @default.
• W4309308595 cites W2093506077 @default.
• W4309308595 cites W2102493768 @default.
• W4309308595 cites W2105697022 @default.
• W4309308595 cites W2106660046 @default.
• W4309308595 cites W2123728657 @default.
• W4309308595 cites W2126018089 @default.
• W4309308595 cites W2136196249 @default.
• W4309308595 cites W2141901504 @default.
• W4309308595 cites W2152346724 @default.
• W4309308595 cites W2162230759 @default.
• W4309308595 cites W2166697674 @default.
• W4309308595 cites W2272919790 @default.
• W4309308595 cites W2312705457 @default.
• W4309308595 cites W2319241025 @default.
• W4309308595 cites W2319772781 @default.
• W4309308595 cites W2584340857 @default.
• W4309308595 cites W2922405587 @default.
• W4309308595 cites W2982433977 @default.
• W4309308595 cites W3022040131 @default.
• W4309308595 cites W3037697093 @default.
• W4309308595 cites W3041710942 @default.
• W4309308595 cites W3125878005 @default.
• W4309308595 cites W3129121287 @default.
• W4309308595 cites W3133853356 @default.
• W4309308595 cites W3186030698 @default.
• W4309308595 cites W3205950597 @default.
• W4309308595 cites W3206567686 @default.
• W4309308595 cites W3216891765 @default.
• W4309308595 cites W4206445149 @default.
• W4309308595 cites W4220781135 @default.
• W4309308595 cites W4223463223 @default.
• W4309308595 cites W4255007839 @default.
• W4309308595 cites W4285022563 @default.
• W4309308595 cites W6543802 @default.
• W4309308595 cites W2402201929 @default.
• W4309308595 doi "https://doi.org/10.5500/wjt.v12.i11.378" @default.
• W4309308595 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36437842" @default.
• W4309308595 hasPublicationYear "2022" @default.
• W4309308595 type Work @default.
• W4309308595 citedByCount "0" @default.
• W4309308595 crossrefType "journal-article" @default.
• W4309308595 hasAuthorship W4309308595A5019327453 @default.
• W4309308595 hasAuthorship W4309308595A5030807436 @default.
• W4309308595 hasAuthorship W4309308595A5035932638 @default.
• W4309308595 hasAuthorship W4309308595A5041107229 @default.
• W4309308595 hasAuthorship W4309308595A5049150425 @default.
• W4309308595 hasAuthorship W4309308595A5049501924 @default.
• W4309308595 hasAuthorship W4309308595A5070484679 @default.
• W4309308595 hasAuthorship W4309308595A5080492388 @default.
• W4309308595 hasAuthorship W4309308595A5083544553 @default.
• W4309308595 hasBestOaLocation W43093085951 @default.
• W4309308595 hasConcept C126322002 @default.
• W4309308595 hasConcept C159654299 @default.
• W4309308595 hasConcept C203014093 @default.
• W4309308595 hasConcept C2778494684 @default.
• W4309308595 hasConcept C2780091579 @default.
• W4309308595 hasConcept C2780303639 @default.
• W4309308595 hasConcept C2911091166 @default.
• W4309308595 hasConcept C45189115 @default.
• W4309308595 hasConcept C71924100 @default.
• W4309308595 hasConcept C90924648 @default.
• W4309308595 hasConceptScore W4309308595C126322002 @default.
• W4309308595 hasConceptScore W4309308595C159654299 @default.
• W4309308595 hasConceptScore W4309308595C203014093 @default.
• W4309308595 hasConceptScore W4309308595C2778494684 @default.
• W4309308595 hasConceptScore W4309308595C2780091579 @default.
• W4309308595 hasConceptScore W4309308595C2780303639 @default.
• W4309308595 hasConceptScore W4309308595C2911091166 @default.

• next